Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an announcement.
Rossini S.à r.l. has completed a secondary placement of approximately 10.5 million ordinary shares in Recordati S.p.A., representing about 5% of Recordati’s share capital. The company will not receive proceeds from this sale, which was priced at €55.70 per share, and the transaction signifies a strategic financial move by Rossini, impacting its stake in Recordati but not affecting the company’s operations directly.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceuticals. The company primarily serves the European market with a range of specialty and primary care products.
YTD Price Performance: 18.08%
Average Trading Volume: 25,998
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €12.33B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.